Metabolic health is not a number.
It is a continuous story told in signals physicians rarely see.
MetAi is grounded in peer-reviewed literature across metabolic health, longevity medicine, body composition science, biometric monitoring, and behaviour change. Every signal we track, every alert threshold, and every clinical protocol traces back to a specific published finding.
Metabolic health is the upstream variable. Everything else follows.
Episodic care cannot produce durable metabolic outcomes. The published evidence is clear — every cardiometabolic improvement reverses when continuity is withdrawn, every protocol depends on what happens during the 364 days between appointments.
Conventional care produces six clinical snapshots a year. MetAi produces three hundred and sixty-five — that's how often biology actually moves. Body composition, biometrics, and bloodwork are the three signal domains where the metabolic story actually unfolds. Together they define whether a patient's trajectory is heading toward longevity or away from it.
This page documents the published research that shaped how we designed MetAi. None of it is marketing. Every claim cites a peer-reviewed source.
What the metabolic health story is actually made of
Weight is a proxy for three underlying clinical realities that physicians need to see directly — and that change continuously between every appointment. Each domain tells a different chapter of the metabolic health story.
Body composition — lean mass, visceral fat, and the metabolic signals weight conceals
Weight tells you how much. Body composition tells you of what. Lean tissue mass drives metabolic rate, glucose disposal, and functional independence with age. Visceral fat is the adipose compartment causally linked to insulin resistance, cardiovascular disease, type 2 diabetes, and all-cause mortality. A scale measures neither.
Biometrics — cardiovascular & sleep signals that precede clinical events
HRV reflects autonomic function and physiological resilience — declining with metabolic stress, sleep disruption, and cardiovascular risk long before symptoms. Resting heart rate, SpO₂, and sleep architecture are equally sensitive early indicators that respond to dietary changes and medication effects in ways that 4–6 week appointment cycles structurally cannot capture.
Bloodwork trends — the metabolic trajectory visible in labs before symptoms declare
Fasting glucose, HbA1c, lipid fractions, inflammatory markers, liver enzymes, and hormone panels trend before disease is declared. They respond to treatment weeks before weight changes — and reverse alongside clinical improvements when continuity is withdrawn. Interpreting these as isolated points at each visit misses the directional story that matters for longevity.
The evidence base MetAi is built on
Nine peer-reviewed papers shape every protocol, every alert threshold, every measurement frequency in the platform. Authorship, journal, and year are listed in full — request access to any full paper via science@metai.health.
A note on our own data
Metamed is a physician-led clinical operator. We do not yet have a published internal outcomes dataset — every statistic on this page is sourced directly from peer-reviewed literature, cited with full authorship, journal, and year. We will share our own outcomes data transparently as it matures.
The research above reflects the evidence base that informed how we designed MetAi — not marketing claims. To review any of the full papers referenced here, email contactus@metamed.health.